133 related articles for article (PubMed ID: 35462530)
21. A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.
Bayo J; Lomas M; Salvador J; Moreno A; Ruiz M; Rodríguez A; Fuentes J; Fernández-Freire A; Bernabé R; Fernández A
Clin Transl Oncol; 2008 Dec; 10(12):817-25. PubMed ID: 19068453
[TBL] [Abstract][Full Text] [Related]
22. Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Cioffi JH; Estes DJ; Florou V; Ardalan B
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29183892
[TBL] [Abstract][Full Text] [Related]
23. [A case of local-recurring breast cancer under long term-treatment by capecitabine].
Yoneyama K; Takeshita T; Suzuki H; Morise M; Suzuki T; Kishi S; Tsutsui A; Matsumoto A
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2623-5. PubMed ID: 22189229
[TBL] [Abstract][Full Text] [Related]
24. A Rare Case of Levetiracetam-Induced Refractory Hypokalemia.
Coughlin P; Patel G; Vadaketh J; Pandit R
Cureus; 2022 Apr; 14(4):e23817. PubMed ID: 35530900
[TBL] [Abstract][Full Text] [Related]
25. A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report.
Liu Z; Wang S; Zhang R; Wang C; Lu J; Shao L
BMC Med Genomics; 2021 Aug; 14(1):198. PubMed ID: 34348722
[TBL] [Abstract][Full Text] [Related]
26. Fluorouracil for allergic reactions to capecitabine.
Liu CY
Ann Pharmacother; 2002 Dec; 36(12):1897-9. PubMed ID: 12452753
[TBL] [Abstract][Full Text] [Related]
27. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
28. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
Schüll B; Scheithauer W; Kornek GV
Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934
[TBL] [Abstract][Full Text] [Related]
29. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.
Bachelot T; Romieu G; Campone M; Diéras V; Cropet C; Dalenc F; Jimenez M; Le Rhun E; Pierga JY; Gonçalves A; Leheurteur M; Domont J; Gutierrez M; Curé H; Ferrero JM; Labbe-Devilliers C
Lancet Oncol; 2013 Jan; 14(1):64-71. PubMed ID: 23122784
[TBL] [Abstract][Full Text] [Related]
30. A life-threatening drug-drug interaction between capecitabine and brivudine in a patient with metastatic breast cancer.
Tsifi A; Papaxoinis G; Diamantopoulos P; Mantzourani M; Antoniadou V; Halioti A; Gogas H
J Chemother; 2019; 31(7-8):424-427. PubMed ID: 31516092
[TBL] [Abstract][Full Text] [Related]
31. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
von Minckwitz G; Conrad B; Reimer T; Decker T; Eidtmann H; Eiermann W; Hackmann J; Möbus V; Marmé F; Potenberg J; Stickeler E; Simon E; Thomssen C; Huober J; Denkert C; Alfer J; Jackisch C; Nekljudova V; Burchardi N; Loibl S;
Cancer; 2015 Oct; 121(20):3639-48. PubMed ID: 26111104
[TBL] [Abstract][Full Text] [Related]
32. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
Bar-Sela G; Haim N
Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
[TBL] [Abstract][Full Text] [Related]
33. A Case of Pseudohyperaldosteronism Induced by Yokukansan and Shakuyakukanzoto That Resulted in Severe Hypokalemia.
Arai M; Isono H; Isono M; Ihara K; Kondo K
Cureus; 2023 Apr; 15(4):e38267. PubMed ID: 37261160
[TBL] [Abstract][Full Text] [Related]
34. Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab.
Shaikh A; Wiisanen ME; Gunderson HD; Leung N
Ann Pharmacother; 2009 Jul; 43(7):1370-3. PubMed ID: 19584382
[TBL] [Abstract][Full Text] [Related]
35. [Side effects of glucocorticosteroids in the management of 1291 patients of SARS].
Li N; Wang GF; Wu YF; Xie GQ; Xiao F; Chen BW; Wang YX; Han DM
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):519-24. PubMed ID: 15489935
[TBL] [Abstract][Full Text] [Related]
36. [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].
Sato T; Nakagawa T; Kuwayama T; Oda G; Sugimoto H; Ishiba T; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2180-2. PubMed ID: 22202322
[TBL] [Abstract][Full Text] [Related]
37. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
Muss HB; Polley MC; Berry DA; Liu H; Cirrincione CT; Theodoulou M; Mauer AM; Kornblith AB; Partridge AH; Dressler LG; Cohen HJ; Kartcheske PA; Perez EA; Wolff AC; Gralow JR; Burstein HJ; Mahmood AA; Sutton LM; Magrinat G; Parker BA; Hart RD; Grenier D; Hurria A; Jatoi A; Norton L; Hudis CA; Winer EP; Carey L
J Clin Oncol; 2019 Sep; 37(26):2338-2348. PubMed ID: 31339827
[TBL] [Abstract][Full Text] [Related]
38. Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge.
Murthy K; Harrington JT; Siegel RD
Endocr Pract; 2005; 11(5):331-4. PubMed ID: 16191494
[TBL] [Abstract][Full Text] [Related]
39. Serial renography for evaluation of the impact of capecitabine therapy on renal function: A case report.
Ren J; Huo Z; Wang X; Liu Y; Yang G
Medicine (Baltimore); 2017 Jun; 96(22):e6861. PubMed ID: 28562534
[TBL] [Abstract][Full Text] [Related]
40. [A case of triple negative recurrent breast cancer successfully treated with capecitabine+docetaxel combination chemotherapy].
Hachisuka Y; Kamei Y; Umeoka T; Kimura M; Uomoto M; Hatano H; Johira H; Yunoki S; Kawata N; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2008 Mar; 35(3):475-8. PubMed ID: 18347398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
